Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

LOUISA 3D

Financiado

Cerrado

Innovative 3 dimensional optoacoustic imaging for safe breast cancer screening

Breast cancer is a global challenge representing the leading cause of death for women worldwide: according to the estimates of WHO, there were over 2 million new cases in 2018, with a projection of more than 3 million individuals... ver más

31/08/2019

Touch TD

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

TOUCH TD LTD No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2019-08-31

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

Touch TD

50.00K€ | Lider

Proyectos interesantes

PAMMOTH

Medical Technol...

Applied Physics

5M€ Cerrado

SOLUS

Medical Technol...

Applied Physics

4M€ Cerrado

EDOCAL

Medical Technol...

Applied Physics

2M€ Cerrado

CPP2021-008751

Medical Technol...

Applied Physics

104K€ Cerrado

LOUISA-3D

Medical Technol...

Applied Physics

71K€ Cerrado

MammoWave

Medical Technol...

Electronics

71K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 3 meses Fecha Inicio: 2019-05-24
Fecha Fin: 2019-08-31

Líder del proyecto

TOUCH TD LTD No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Breast cancer is a global challenge representing the leading cause of death for women worldwide: according to the estimates of WHO, there were over 2 million new cases in 2018, with a projection of more than 3 million individuals by 2040. It is usually diagnosed at an advanced stage while early detection greatly increases the chances for successful treatment. The 2 components of early detection are mass screening and early diagnosis. Currently, most diffuse population-based screening programs for breast cancer are based on mammography. Weighing the harms against the benefits of these programs has led WHO not to recommend mammography screening in women less than 50 years of age. Mammography has been the medical industry’s gold standard breast cancer screening tool for nearly four decades. Today a number of adverse effects, backed up by mounting scientific evidence, are limiting the use of mammography as a mass screening device. LOUISA-3D uses safe light and sound to provide safer and accurate breast cancer screening. The LOUISA-3D innovation consists of a novel optoacoustic imaging method that allows one to see under the skin through the tissues with high spatial resolution by listening to the sound of light absorbed in the body which can be used for detection and diagnostics of cancer and vascular diseases. During the phase 1 project, a go-to-market strategy and a supply chain will be established, as well as further development plan will be drafted. Within the overall innovation project Tomowave will finalize its engineering of LOUISA-3D before scaling up for clinical trials and system industrialization.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores